Procedural and Post-Procedural Clinical Performance of a Novel Peripheral Intravenous Needle Over Catheter Device (OspreyTM)
Emergency Department Patients who were to get intravenous (IV) access through routine medical care will receive it through trademarked catheter via convenience sample. Patient and clinician experience, including adverse events, will be recorded. A standardized data entry sheet will be collected at time of enrollment, and then daily thereafter while the subject has the IV. The data collected will remain anonymous.
Randomized Trial Evaluating Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis - RELIEF-SCC
Sickle cell crisis continues to be a frequent presentation to emergency departments. Patients presenting will often require immediate treatment for their pain and often times this will include opioids. The opioid epidemic has cost thousands of lives; and continues to be a significant problem posing several challenges when treating patients presenting with sickle cell disease. Primarily, opioids remain the mainstay of treatment for these patients and the push to address the opioid crisis may present challenges for adequate opioid administration in patients suffering from a sickle cell crisis while hospitals find ways to curb the opioid crisis overall. Opioid treatment for patients in acute vaso-occlusive crisis has significantly contributed to quality of life and life expectancy of patients with this diagnosis. Measures should continue to attempt to administer a multi-model approach to sickle cell patients to minimize the morphine milligram equivalents in these patients while also successfully addressing the patient's pain. IV lidocaine is a pain medication that has been evaluated in several painful experiences, such as in renal colic. A few case reports have shown IV lidocaine use in sickle cell can be a potential effective adjunct medication to opioids to treat pain and reduce further opioid requirements. Currently, no prospective controlled trial exists to evaluate the true benefit of IV lidocaine in this population. Our study aims to evaluate IV lidocaine as an adjunct to opioid treatment in the emergency department to determine if improved pain is achieved and if there is a reduction in overall morphine milligram equivalents throughout the emergency department visit.
Bias Reduction in Academic Recruitment
The aim of this study is to determine if, with respect to medical students applying for residency in emergency medicine, prior knowledge of an applicant's academic record affects their ranking during their interviews.
Attendings interviewing candidates will either be blinded to their prior academic records or be allowed to review them prior to the interview. The interviewer's final score of the applicant will be measured, comparing blinded versus unblinded assessors.
100 项与 Community Medical Center 相关的临床结果
0 项与 Community Medical Center 相关的专利(医药)
2024-05-01·A36. PROGRESS IN LUNG CANCER AND LUNG CANCER SCREENING
Underutilization of Low-dose Computed Tomography Scan for Lung Cancer Screening
作者: Rodriguez, C. ; Khan, W. ; DiVanna, M. ; Qaiser, S. ; Yosry, N.
2024-05-01·B44. MITIGATING HARM: MANAGING EXPECTED AND UNEXPECTED COMPLICATIONS IN THE ICU
Real-World Administration of Dantrolene: Harder Than a Board Exam
作者: Rodriguez, C. ; Amir, N. ; Luzuriaga, A. ; Divanna, M. ; Qaiser, S.
2024-05-01·A43. SHOCK AND AWE: NOVEL SHOCK CASES IN THE ICU
作者: Luzuriaga, A. ; Qaiser, S. ; Rodriguez, C. ; Adelizzi, A. ; Yosry, N.
100 项与 Community Medical Center 相关的药物交易
100 项与 Community Medical Center 相关的转化医学